NCT04003116 - Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 11, 2019

Primary Completion Date

April 24, 2022

Study Completion Date

July 25, 2022

Conditions

Pulmonary Embolism

Interventions

DRUG

Oxygen gas

Supplementary oxygen during the first 48 hours added to conventional anticoagulant treatment. Patients will receive anticoagulant treatment according to updated guidelines.

Trial Locations (7)

Unknown

Hospital Universitario Araba, Vitoria-Gasteiz

Hospital Galdakao-Usansolo, Galdakao

Hospital Clínic de Barcelona, Barcelona

Clínica Universidad de Navarra, Madrid

Hospital Universitario Ramón y Cajal, Madrid

Hospital Universitario Virgen del Rocío, Seville

Hospital Universitario y Politécnico La Fe, Valencia

All Listed Sponsors

collaborator

Sociedad Española de Neumología y Cirugía Torácica

OTHER

lead

Ministry of Health, Spain

OTHER_GOV